Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Boehringer Ingelheim
UBS
Citi
QuintilesIMS
Colorcon
Argus Health
AstraZeneca
Harvard Business School
Daiichi Sankyo

Generated: January 17, 2018

DrugPatentWatch Database Preview

Carbidopa; levodopa - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for carbidopa; levodopa and what is the scope of carbidopa; levodopa patent protection?

Carbidopa; levodopa
is the generic ingredient in seven branded drugs marketed by Impax Labs Inc, Abbvie Inc, Accord Hlthcare, Apotex, Impax Labs, Kv Pharm, Mylan, Sun Pharm Inds, Merck Sharp Dohme, Ranbaxy, Sun Pharma Global, Ucb Inc, Actavis Elizabeth, Apotex Inc, Idt Australia Ltd, Mayne Pharma, SCS, and Watson Labs, and is included in twenty-nine NDAs. There are eight patents protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

Carbidopa; levodopa has thirty-five patent family members in fourteen countries.

There are eighteen drug master file entries for carbidopa; levodopa. Thirty-two suppliers are listed for this compound.
Summary for carbidopa; levodopa
International Patents:35
US Patents:8
Tradenames:7
Applicants:18
NDAs:29
Drug Master File Entries: 18
Suppliers / Packagers: 32
Clinical Trials: 342
Drug Prices:see low prices
DailyMed Link:carbidopa; levodopa at DailyMed
Pharmacology for carbidopa; levodopa

US Patents and Regulatory Information for carbidopa; levodopa

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Merck Sharp Dohme SINEMET CR carbidopa; levodopa TABLET, EXTENDED RELEASE;ORAL 019856-001 May 30, 1991 AB RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Impax Labs Inc RYTARY carbidopa; levodopa CAPSULE, EXTENDED RELEASE;ORAL 203312-003 Jan 7, 2015 RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Impax Labs Inc RYTARY carbidopa; levodopa CAPSULE, EXTENDED RELEASE;ORAL 203312-004 Jan 7, 2015 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Merck Sharp Dohme SINEMET carbidopa; levodopa TABLET;ORAL 017555-001 Approved Prior to Jan 1, 1982 AB RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ranbaxy CARBILEV carbidopa; levodopa TABLET, FOR SUSPENSION;ORAL 076643-001 Jun 10, 2005 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Impax Labs Inc RYTARY carbidopa; levodopa CAPSULE, EXTENDED RELEASE;ORAL 203312-004 Jan 7, 2015 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Impax Labs CARBIDOPA AND LEVODOPA carbidopa; levodopa TABLET, EXTENDED RELEASE;ORAL 076521-002 May 14, 2004 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Impax Labs Inc RYTARY carbidopa; levodopa CAPSULE, EXTENDED RELEASE;ORAL 203312-004 Jan 7, 2015 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ranbaxy CARBILEV carbidopa; levodopa TABLET, FOR SUSPENSION;ORAL 076643-002 Jun 10, 2005 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Impax Labs Inc RYTARY carbidopa; levodopa CAPSULE, EXTENDED RELEASE;ORAL 203312-002 Jan 7, 2015 RX Yes No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for carbidopa; levodopa

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Merck Sharp Dohme SINEMET CR carbidopa; levodopa TABLET, EXTENDED RELEASE;ORAL 019856-001 May 30, 1991 ➤ Subscribe ➤ Subscribe
Merck Sharp Dohme SINEMET carbidopa; levodopa TABLET;ORAL 017555-003 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Merck Sharp Dohme SINEMET CR carbidopa; levodopa TABLET, EXTENDED RELEASE;ORAL 019856-002 Dec 24, 1992 ➤ Subscribe ➤ Subscribe
Merck Sharp Dohme SINEMET carbidopa; levodopa TABLET;ORAL 017555-002 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Merck Sharp Dohme SINEMET carbidopa; levodopa TABLET;ORAL 017555-002 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Merck Sharp Dohme SINEMET carbidopa; levodopa TABLET;ORAL 017555-001 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Merck Sharp Dohme SINEMET carbidopa; levodopa TABLET;ORAL 017555-003 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Merck Sharp Dohme SINEMET carbidopa; levodopa TABLET;ORAL 017555-003 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Merck Sharp Dohme SINEMET carbidopa; levodopa TABLET;ORAL 017555-001 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Merck Sharp Dohme SINEMET carbidopa; levodopa TABLET;ORAL 017555-002 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for carbidopa; levodopa

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Baxter
Daiichi Sankyo
Medtronic
Covington
Deloitte
Chinese Patent Office
QuintilesIMS
Fish and Richardson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot